Back to previous page

Plan. Prepare. Protect Your Patients.

Video transcript

On Screen Text

PLAN. PREPARE. PROTECT.

PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION AVAILABLE ON THIS WEBSITE.

On Screen Text

Plan. Prepare. Protect.

Review the immunization schedule and ensure your appropriate older adult patients are up to date with recommended vaccinations, so they can be ready for an AREXVY vaccination against RSV-LRTD in the fall.

[Immunization schedule chart]

May 2023: AREXVY FDA Approval1,2

June 2023: Anticipated ACIP vote2

AREXVY Available2

RSV & Flu Season3*

*RSV infections occur primarily during the fall and winter flu season but can vary by region in the United States.4

ACIP=Advisory Committee on Immunization Practices; FDA=Food and Drug Administration; LRTD=lower respiratory tract disease; RSV=respiratory syncytial virus.

1. Prescribing Information for AREXVY. 2. US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults | GSK 2023. https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ 3. Centers for Disease Control and Prevention. Accessed June 29, 2022. https://emergency.cdc.gov/han/2021/han00443.asp 4. Centers for Disease Control and Prevention. Accessed April 17, 2023. https://www.cdc.gov/rsv/clinical/index.html

PLEASE SEE IMPORTANT SAFETY INFORMATION AND FULL PRESCRIBING INFORMATION AVAILABLE ON THIS WEBSITE.

Audio

Today, we've learned about AREXVY—an approved vaccine to protect adults 60 years and older against RSV lower respiratory tract disease.

So, what should you do now? Well, here's what I think: Plan ahead to ensure patients receive AREXVY this fall.

Apply a long-term strategy to your adult immunization program. Given the crowded nature of the adult schedule, assess what other recommended vaccines may be given to your patients now before respiratory season begins.

Listen, I... I recognize how challenging it can be to get your patients to prioritize vaccines when it may feel like there are so many to recommend. But help yourself. And, more importantly, help your patients by getting them caught up with their recommended vaccines, and make room to protect them from RSV-LRTD with AREXVY this fall.

On Screen Text

AREXVY (RESPIRATORY SYNCYTIAL VIRUS VACCINE, ADJUVANTED)

For more information on the CDC recommendation for RSV vaccination, visit the CDC website.

For information on AREXVY, visit AREXVYhcp.com.

On Screen Text

Intended for US healthcare professionals only.

Trademarks are owned by or licensed to the GSK group of companies.

©2023 GSK or licensor.

RSAVID230043 July 2023

Produced in USA.

Please see Important Safety Information and full Prescribing Information available on this website.

close